The Ebola threat is real here in the U.S. And the major concern among the CDC, the agency that Americans
have to put their trust in is that the funding for such a sterile operation is not adequate enough.
However, our top public officials have apparently collected $25 million dollars over the past seven years and are now pointing the finger at the Obama administration for not rushing to their financial defense.
You and I and all U.S. taxpayers have given the Center for Disease Control $6 billion in salaries and $25 million in bonuses to a very specific body of health care specialists since 2007.
The CDC’s irresponsibility in blaming the government comes from a data compilation by American Transparency’s OpenTheBooks.com that carefully documented 1.3 billion lines of federal, state and local spending found:
“The agency’s head count increased by 23 percent during that time, adding manpower and contributing to higher payrolls despite relatively flat funding.”
All federal wages were frozen from 2010-2013 due to budgetary constraints, but the CDC took no notice and found ways to dole out bonuses and within-grade increases and promotional pay raises to keep the the specialists well-cushioned, as exemplified here:
Donald Shriber, deputy director of policy and communication at the CDC’s Center for Global Health, received the highest bonus in the six years analyzed — $62,895 in 2011 — netting $242,595 in take-home pay in a year when wages were supposed to be frozen.
ButDonna Hansen, media rep for the CDC says Shriber ,along with three others in the CDC’s Department of Health and Human Services, earned this for receiving the Presidential Rank Award for his leadership abilities. Even the deputy budget director Kathleen Dunlap was awarded $8000 as a bonus last year, but kept mum when asked to comment.
National Institutes of Health Director Francis Collins told The Huffington Post last week that the CDC had been working on an Ebola vaccine for more than a decade but was hampered by shrinking budgets.
“Frankly, if we had not gone through our 10-year slide in research support, we probably would have had a vaccine in time for this that would’ve gone through clinical trials and would have been ready,” Mr. Collins told the news site.
h/t: The Washington Times